cyclosporine has been researched along with Ischemic Attack, Transient in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (53.33) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 4 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyashita, R; Murozono, M; Ogiwara, Y; Sato, E; Takeda, A; Ynagita, K | 1 |
| Forsse, A; Gramsbergen, JB; Nielsen, TH; Nordström, CH; Nygaard, KH; Poulsen, FR | 1 |
| Hokari, M; Iwasaki, Y; Kuroda, S | 1 |
| Aguettaz, P; Berthezène, Y; Campuzano, O; Charriaut-Marlangue, C; Chauveau, F; Cho, TH; Nighoghossian, N; Ovize, M; Riou, A; Wiart, M | 1 |
| Isshiki, A; Matsumoto, S; Watanabe, Y; Wieloch, T | 1 |
| Abe, H; Houkin, K; Iwasaki, Y; Kobayashi, T; Kuroda, S; Tada, M | 1 |
| Buzañska, L; Domañska-Janik, K; Dłuzniewska, J; Kozłowska, H; Sarnowska, A; Zabłocka, B | 1 |
| Isshiki, A; Matsumoto, E; Matsumoto, S; Murozono, M; Watanabe, Y | 1 |
| Borlongan, CV; Hess, DC; Matsukawa, N; Sanberg, PR; Wang, Y; Xu, L; Yu, G | 1 |
| Isshiki, A; Miyata, K; Shibasaki, F; Uchino, H; Yamaguchi, T | 1 |
| Furuichi, Y; Hino, M; Maemoto, T; Matsuoka, N; Moriguchi, A; Muramatsu, Y; Nakada, H; Tojo, N | 1 |
| Hamada, K; Iwama, J; Iwamoto, S; Kirino, T; Mori, T; Nagata, K; Nirei, H; Sasaki, T | 1 |
| Asanuma, M; Iwata, E; Kondo, Y; Mori, A; Nishibayashi, S; Ogawa, N | 1 |
| Kikuchi, H; Okamoto, S; Yanamoto, H | 1 |
| Andrychowski, J; Barczewska, M; Bojarski, P; Dziewiecki, C; Pastuszko, M; Ryba, M | 1 |
| Asanuma, M; Kondo, Y; Mizukawa, K; Mori, A; Ogawa, N; Tanaka, K | 1 |
| Elmér, E; Lindvall, O; Siesjö, BK; Uchino, H; Uchino, K | 1 |
| Kitagawa, K; Mabuchi, T; Matsumoto, M; Matsushita, K; Ohtsuki, T; Taguchi, A; Yagita, Y; Yanagihara, T | 1 |
| Gress, DR; Manno, EM; Ogilvy, CS; Stone, CM; Zervas, NT | 1 |
| Elmér, E; Li, PA; Siesjö, BK; Uchino, H | 1 |
| Pihko, H | 1 |
| Elmér, E; He, QP; Li, PA; Siesjö, BK; Smith, ML; Uchino, H; Uchino, K | 1 |
| Asanuma, M; Iwata, E; Kondo, F; Kondo, Y; Miyazaki, I; Ogawa, N | 1 |
| Janelidze, S; Kuroda, S; Siesjö, BK | 1 |
| Siesjö, BK; Yoshimoto, T | 1 |
| Kumon, Y; Maeda, N; Nakatsuka, H; Ohta, S; Sakaki, S; Sakanaka, M; Tanaka, J; Toku, K | 1 |
| He, QP; Kristián, T; Li, PA; Siesjö, BK | 1 |
| He, QP; Li, PA; Siesjö, BK; Uchino, H; Yoshimoto, T | 1 |
| Hu, B; Kristián, T; Ouyang, YB; Siesjö, BK; Yoshimoto, T | 1 |
| Bidzinski, J; Dziewiecki, C; Iwanska, K; Pastuszko, M; Ryba, M | 1 |
1 trial(s) available for cyclosporine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Cyclosporine A prevents neurological deterioration of patients with SAH--a preliminary report.
Topics: Adult; Autoimmune Diseases; Cyclosporine; Female; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Rupture, Spontaneous; Subarachnoid Hemorrhage; Treatment Outcome | 1991 |
29 other study(ies) available for cyclosporine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Co-administration of Cyclosporin A and Ondansetron decreases transient local cerebral ischemic injury in the mouse.
Topics: Animals; Cerebrovascular Circulation; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Ischemic Attack, Transient; Male; Mice; Mice, Inbred ICR; Neuroprotective Agents; Ondansetron; Treatment Outcome | 2017 |
Cyclosporin A ameliorates cerebral oxidative metabolism and infarct size in the endothelin-1 rat model of transient cerebral ischaemia.
Topics: Animals; Brain Ischemia; Cell Respiration; Cyclosporine; Endothelin-1; Infarction; Ischemic Attack, Transient; Male; Microdialysis; Mitochondria; Oxidative Stress; Rats; Rats, Sprague-Dawley; Stroke | 2019 |
Pretreatment with the ciclosporin derivative NIM811 reduces delayed neuronal death in the hippocampus after transient forebrain ischaemia.
Topics: Animals; Apoptosis; Benzimidazoles; Carbocyanines; Cyclosporine; Glutamic Acid; Hippocampus; In Situ Nick-End Labeling; Ischemic Attack, Transient; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Neurons; Neuroprotective Agents; Permeability; Prosencephalon | 2010 |
Pre- and post-treatment with cyclosporine A in a rat model of transient focal cerebral ischaemia with multimodal MRI screening.
Topics: Animals; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Rats; Rats, Sprague-Dawley | 2013 |
Restricted clinical efficacy of cyclosporin A on rat transient middle cerebral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Blood-Brain Barrier; Brain; Coloring Agents; Cyclosporine; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neuroprotective Agents; Rats; Rats, Wistar; Tetrazolium Salts | 2002 |
Calcium-induced mitochondrial swelling and cytochrome c release in the brain: its biochemical characteristics and implication in ischemic neuronal injury.
Topics: Animals; Brain; Calcium; Cell Death; Cyclosporine; Cytochrome c Group; Dopamine Antagonists; Gerbillinae; Hippocampus; Immunoblotting; Ischemic Attack, Transient; Male; Microscopy, Electron; Mitochondria; Mitochondria, Liver; Mitochondrial Swelling; Neurons; Oxygen Consumption; Permeability; Rats; Rats, Wistar; Trifluoperazine | 2003 |
Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm.
Topics: Analysis of Variance; Animals; Biological Transport; Blotting, Western; Brain Ischemia; Cell Count; Cell Death; Cerebral Cortex; Cyclosporine; Cytochromes c; Cytoplasm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Gerbillinae; Glutamic Acid; Hippocampus; Hydrogen Peroxide; Immunosuppressive Agents; In Vitro Techniques; Ischemic Attack, Transient; Male; Microscopy, Confocal; Rats; Rats, Wistar; Staurosporine; Tacrolimus; Time Factors; Tubulin | 2004 |
Neuroprotective and neurotoxic effects of cyclosporine A on transient focal ischemia in mdr1a knockout mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Cerebral Infarction; Cyclosporine; Dose-Response Relationship, Drug; Ischemic Attack, Transient; Male; Mice; Mice, Knockout; Neuroprotective Agents; Time Factors | 2004 |
Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke.
Topics: Animals; Avoidance Learning; Behavior, Animal; Brain; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Maze Learning; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2005 |
Effect of cyclosporin a on immediate early gene in rat global ischemia and its neuroprotection.
Topics: Animals; Cell Death; Cyclosporine; Disease Models, Animal; Genes, Immediate-Early; Hippocampus; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Mitogen-Activated Protein Kinases; Neurons; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger; Time Factors | 2006 |
Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models.
Topics: Animals; Cell Line, Tumor; Cyclosporine; Gerbillinae; Humans; Hypoxia, Brain; In Vitro Techniques; Ischemic Attack, Transient; Lymphocyte Culture Test, Mixed; Mitochondria; Neuroprotective Agents; Rats | 2007 |
Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model.
Topics: Animals; Cyclosporine; Dogs; Immunosuppressive Agents; Interleukin-2; Ischemic Attack, Transient; Subarachnoid Hemorrhage; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Tacrolimus | 1993 |
Cyclosporin A prevents ischemia-induced reduction of muscarinic acetylcholine receptors with suppression of microglial activation in gerbil hippocampus.
Topics: Animals; Cyclosporine; Cytokines; Depression, Chemical; Gerbillinae; Hippocampus; Immunohistochemistry; Ischemic Attack, Transient; Kinetics; Macrophage Activation; Microglia; Receptors, Muscarinic | 1995 |
Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
Topics: Animals; Benzamidines; Betamethasone; Cyclosporine; Drug Administration Schedule; Gabexate; Guanidines; Ischemic Attack, Transient; Rabbits; Random Allocation; Serine Proteinase Inhibitors; Subarachnoid Hemorrhage | 1994 |
A strategy for analyzing multiple parameters with application to aneurysmal SAH patients all of them clipped but treated with and without cyclosporine.
Topics: Adult; Aged; Aneurysm, Ruptured; Cyclosporine; Drug Therapy, Combination; Female; Glasgow Coma Scale; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Microsurgery; Middle Aged; Neurologic Examination; Nimodipine; Postoperative Complications; Subarachnoid Hemorrhage | 1993 |
The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia.
Topics: Animals; Cyclosporine; Down-Regulation; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Prosencephalon; Receptors, Muscarinic | 1993 |
Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat.
Topics: Amino Acid Isomerases; Animals; Brain Injuries; Carrier Proteins; Cyclosporine; Hippocampus; Immunosuppressive Agents; Ischemic Attack, Transient; Mitochondria; Peptidylprolyl Isomerase; Rats | 1995 |
Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils.
Topics: Animals; Body Temperature; Cell Death; Cyclosporine; Female; Gerbillinae; Hippocampus; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Nerve Degeneration; Neuroprotective Agents; Pyramidal Cells; Tacrolimus | 1996 |
The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Blood Flow Velocity; Critical Care; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Middle Aged; Neurologic Examination; Pilot Projects; Subarachnoid Hemorrhage; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 1997 |
Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia.
Topics: Analysis of Variance; Animals; Brain Damage, Chronic; Cerebral Cortex; Cyclosporine; Drug Evaluation, Preclinical; Hippocampus; Hydrogen-Ion Concentration; Hyperglycemia; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Prosencephalon; Rats; Rats, Wistar; Seizures; Substantia Nigra | 1997 |
Hypertensive encephalopathy in children with malignant disease.
Topics: Adolescent; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Hypertension; Immunosuppressive Agents; Ischemic Attack, Transient; Occipital Lobe; Parietal Lobe; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Syndrome | 1997 |
Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Cyclosporine; Immunosuppressive Agents; Ischemic Attack, Transient; Neuroprotective Agents; Prosencephalon; Rats; Treatment Outcome | 1998 |
Early treatment with cyclosporin A ameliorates the reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia.
Topics: Animals; Cyclosporine; Down-Regulation; Gerbillinae; Hippocampus; Histocytochemistry; Immunohistochemistry; Ischemic Attack, Transient; Lectins; Male; Microglia; Neuroprotective Agents; Prosencephalon; Receptors, Muscarinic; Time Factors | 1999 |
The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats.
Topics: Analysis of Variance; Animals; Arterial Occlusive Diseases; Cerebral Infarction; Cyclosporine; Hyperglycemia; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Neuroprotective Agents; Rats; Rats, Wistar; Tacrolimus; Treatment Outcome | 1999 |
Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.
Topics: Animals; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain Injuries; Carbon Dioxide; Carotid Arteries; Cyclosporine; Diuretics, Osmotic; Hydrogen-Ion Concentration; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Injections, Intra-Arterial; Ischemic Attack, Transient; Male; Mannitol; Osmosis; Oxygen; Rats; Rats, Wistar; Sodium Chloride; Tacrolimus; Wounds, Stab | 1999 |
Release of cytochrome c from mitochondria to cytosol in gerbil hippocampal CA1 neurons after transient forebrain ischemia.
Topics: Animals; Cerebral Ventricles; Cyclosporine; Cytosol; Electron Transport Complex IV; Gerbillinae; Hippocampus; Injections, Intraventricular; Ischemic Attack, Transient; Male; Mitochondria; Neurons | 1999 |
Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia.
Topics: Animals; Brain Damage, Chronic; Cerebrovascular Circulation; Cyclosporine; Ischemic Attack, Transient; Male; Mitochondria; Neuroprotective Agents; Oxygen Consumption; Rats; Rats, Wistar; Time Factors | 2000 |
Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat.
Topics: Animals; Brain; Cyclosporine; Down-Regulation; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Tacrolimus | 2001 |
Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
Topics: Animals; Benzenesulfonates; Cyclosporine; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Mitochondria; Neuroprotective Agents; Nitrogen Oxides; Rats; Rats, Wistar | 2002 |